Glenmede Trust’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,484
| Closed | -$13K | – | 2227 |
|
|
2020
Q3 | $13K | Hold |
1,484
| – | – | ﹤0.01% | 1790 |
|
|
2020
Q2 | $16K | Buy |
1,484
+248
| +20% | +$2.67K | ﹤0.01% | 1686 |
|
|
2020
Q1 | $20K | Hold |
1,236
| – | – | ﹤0.01% | 2106 |
|
|
2019
Q4 | $20K | Buy |
1,236
+169
| +16% | +$2.74K | ﹤0.01% | 2106 |
|
|
2019
Q3 | $13 | Sell |
1,067
-425,659
| -100% | -$5.19K | ﹤0.01% | 2252 |
|
|
2019
Q2 | $6.01K | Sell |
426,726
-1,381,475
| -76% | -$19.5K | 0.03% | 437 |
|
|
2019
Q1 | $33.3K | Buy |
1,808,201
+534,990
| +42% | +$9.84K | 0.15% | 210 |
|
|
2018
Q4 | $33.3K | Sell |
1,273,211
-493,535
| -28% | -$12.9K | 0.16% | 179 |
|
|
2018
Q3 | $40.5M | Buy |
1,766,746
+1,766,208
| +328,291% | +$40.5M | 0.16% | 200 |
|
|
2018
Q2 | $10K | Sell |
538
-36
| -6% | -$669 | ﹤0.01% | 1909 |
|
|
2018
Q1 | $8K | Hold |
574
| – | – | ﹤0.01% | 2265 |
|
|
2017
Q4 | $8K | Buy |
+574
| New | +$8K | ﹤0.01% | 2265 |
|